Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aslan Pharmaceuticals Ltd ADR (ASLN)

Aslan Pharmaceuticals Ltd ADR (ASLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aslan Pharmaceuticals Ltd ADR 83 CLEMENCEAU AVENUE 12-03 UE SQUARE SINGAPORE U0 239920 SGP

P: 65-6222-4235

Description:

ASLAN Pharmaceuticals Limited operates as a clinical-stage biotechnology company. It develops drugs, medicines and novel therapeutics for the treatment of patients with oncology, respiratory and inflammatory diseases. The company's product portfolio includes Varlitinib, ASLAN004, ASLAN002 and ASLAN003 both are in clinical stage. ASLAN Pharmaceuticals Limited is based in Singapore.

Key Statistics

Overview:

Market Capitalization, $K 30,768
Shares Outstanding, K 32,050
Annual Sales, $ 3,000 K
Annual Net Income, $ -47,070 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,560 K
60-Month Beta 2.79
% of Institutional Shareholders 10.28%
Float, K 32,050
% Float 100.00%

Growth:

1-Year Return -75.62%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/04/20
Earnings Per Share ttm -0.63
EPS Growth vs. Prev Qtr -566.67%
EPS Growth vs. Prev Year 42.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ASLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -5.64
Price/Earnings to Growth N/A
Return-on-Equity % -167.06%
Return-on-Assets % -67.33%
Profit Margin % -1,569.00
Net Margin % N/A
Debt/Equity N/A
Price/Sales 10.90
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -50.84
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar